Search hospitals > Missouri > Springfield
CoxHealth South Hospital
Claim this profileSpringfield, Missouri 65807
Global Leader in Parotid Gland Cancer
Global Leader in Cervical Adenocarcinoma
Conducts research for Relapse
Conducts research for Cancer
Conducts research for Breast Cancer
391 reported clinical trials
9 medical researchers
Summary
CoxHealth South Hospital is a medical facility located in Springfield, Missouri. This center is recognized for care of Parotid Gland Cancer, Cervical Adenocarcinoma, Relapse, Cancer, Breast Cancer and other specialties. CoxHealth South Hospital is involved with conducting 391 clinical trials across 579 conditions. There are 9 research doctors associated with this hospital, such as Jay W Carlson, Tania Papsdorf, MD, Srikant Nannapaneni, and Benjamin Lisle, MD.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Cervical Adenocarcinoma
Global LeaderStage IV
Stage III
Stage II
Top PIs
Jay W CarlsonMercy Hospital Saint Louis6 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Cancer
219 reported clinical trials
294 drugs studied
Tania Papsdorf, MDCoxHealth3 years of reported clinical research
Studies Motor Neuron Disease
Studies Amyotrophic Lateral Sclerosis
2 reported clinical trials
2 drugs studied
Srikant NannapaneniCox South Hospital5 years of reported clinical research
Studies Skin Cancer
Studies Melanoma
2 reported clinical trials
3 drugs studied
Benjamin Lisle, MDCox Medical Center South5 years of reported clinical research
Studies Stroke
Studies Intracerebral Hemorrhage
2 reported clinical trials
3 drugs studied
Clinical Trials running at CoxHealth South Hospital
Breast Cancer
Lung Cancer
Bladder Cancer
Parotid Gland Cancer
Cancer
Breast cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Bladder Carcinoma
Ovarian Cancer
Nanosomal Docetaxel
for Triple Negative Breast Cancer
This trial tests a new, safer form of the cancer drug docetaxel, called Nanosomal Docetaxel Lipid Suspension (NDLS), in patients with advanced or spreading triple-negative breast cancer. NDLS aims to reduce side effects by using tiny fat particles. The drug works by stopping cancer cells from dividing and growing. Docetaxel is a widely used chemotherapy drug, and newer formulations like Nanosomal Docetaxel Lipid Suspension (NDLS) aim to improve its efficacy and reduce toxicity.
Recruiting4 awards Phase 313 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at CoxHealth South Hospital?
CoxHealth South Hospital is a medical facility located in Springfield, Missouri. This center is recognized for care of Parotid Gland Cancer, Cervical Adenocarcinoma, Relapse, Cancer, Breast Cancer and other specialties. CoxHealth South Hospital is involved with conducting 391 clinical trials across 579 conditions. There are 9 research doctors associated with this hospital, such as Jay W Carlson, Tania Papsdorf, MD, Srikant Nannapaneni, and Benjamin Lisle, MD.
Where is CoxHealth South Hospital located?
CoxHealth South Hospital is located at 3801 S. National Ave., Springfield, MO 65807.
Who should I call to ask about financial aid or insurance network?
For financial assistance at CoxHealth South Hospital, please call a financial counselor at 417-269-3117. For insurance-related inquiries, insured individuals should contact their provider, while uninsured individuals should refer to Schedule 6. For general inquiries, contact CoxHealth at 417-269-3000.
What insurance does CoxHealth South Hospital accept?
CoxHealth South Hospital accepts a wide range of insurance plans, such as Humana Commercial Products, Humana Medicare Advantage, Healthy Blue Missouri (Managed Medicaid), MedRisk, LLC, UnitedHealthcare, Aetna, Anthem, Blue Cross Blue Shield, Cigna, Mid America Health, and One Health Plan. Always verify with the hospital or your insurance provider to confirm coverage.
What awards or recognition has CoxHealth South Hospital received?
CoxHealth South Hospital, located in Springfield, Missouri, is a Certified Treatment Center of Excellence for its ALS Clinic, as recognized by The ALS Association. Furthermore, CoxHealth's Springfield hospitals, including Cox Medical Center South, have achieved Magnet recognition, signifying excellence in nursing and high-quality patient care.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.